Chemesis International Inc. Receives Awards for its Highly Recognized Products in Puerto Rico
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
Chemesis International Inc. Receives Awards for its Highly Recognized Products in Puerto Rico
Chemesis’ Subsidiary Natural Ventures Receives Awards for Best Topical, Best Tincture, & Best Vaporizer
April 5, 2019
Vancouver, British Columbia – Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the
“Company” or “Chemesis”), announces it subsidiary Natural Ventures has been awarded best topical,
best tincture, and best vaporizer at a gala held in Puerto Rico that recognizes industry leaders. The gala
was held by t he FreeJuana Foundation , a non-profit organization dedicated to the education and
responsible use of cannabis and its medicinal benefits.
The FreeJuana Foundation is the first and largest pro-cannabis foundation in Puerto Rico, and it also holds
an annual march that helps raise awareness of the benefits of cannabis use. In addition, the group helps
bring together experts and policy makers to help shape regulations in Puerto Rico. The Foundation held a
gala where over 45 companies participated to recognize those that are committed to their patients and
developing the canna bis industry in Puerto Rico , the se awards were given through a survey that is
conducted among dispensary owners, industry leaders and certified patients of medical cannabis.
“We are extremely honoured to have received such high recognition for our continued dedication to
producing products that are of the highest quality,” said CEO of Chemesis, Edgar Montero. “Receiving this
recognition through a survey of our peers is validation that our team has developed the right approach to
producing our finished goods . Chemesis will continue to employ these strategies and maintain its
consistency in all areas of our business.”
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated global leader in the cannabis industry, currently
operating within California, Puerto Rico, and Colombia.
Chemesis is developing a strong foothold in key markets, from cultivation, to manufacturing, distribution
and retail. Chemesis has facilities in both Puerto Rico and California, allowing for cost effective production
and distribution of its products. In addition, Chemesis leverages exclusive brands and partnerships and
uses the highest quality extraction methods to provide consumers with quality cannabis products.
Chemesis will add shareholder value by exploring opportunities in emerging markets while consistently
delivering quality product to its consumers from seed to sale.
Investor Relations:
Chemesis, Inc. (CSE: CSI) (OTC: CADMF) (FRA:CWAA)
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
CaliforniaSap.instagram
Jay&SB.instagram
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of
applicable securities laws relating to statements regarding the transactions contemplated by the Agreement and the
Company's business, products and future of the Company’s business, its expansion plans, product offerings and plans
for sales and marketing. Although the Company believes that the expectations reflected in the forward -looking
information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are
cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject
to risks and uncertainties that may cause actual results, performance and developments to differ materially from
those contemplated by these statements, including, among other things, the risks that the transactions contemplated
by the Agreement will not complete as anticipated, or at all, that the Company's products and plans, particularly with
respect to expansion into retail and other op portunities, will vary from those stated in this news release, that the
anticipated benefits of the proposed alliance with GSRX will not materialize as expected, or at all, and that the
Company may not be able to carry out its business plans as expected. E xcept as required by law, the Company
expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking
information in this news release. Although the Company believes that the expectations reflected in the forward-
looking information are reasonable, there can be no assurance that such expectations will prove to be correct and
makes no reference to profitability based on sales reported. The statements in this news release are made as of the
date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release